Chinese General Practice ›› 2023, Vol. 26 ›› Issue (03): 304-307.DOI: 10.12114/j.issn.1007-9572.2022.0492
• Original Research • Previous Articles Next Articles
Received:
2022-07-08
Revised:
2022-09-20
Published:
2023-01-20
Online:
2022-09-28
Contact:
LIU Linhua
About author:
通讯作者:
刘林华
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0492
组别 | 例数 | 年龄〔M(P25,P75),岁〕 | 性别(男/女) | FPG〔M(P25,P75),mmol/L〕 | 尿酸〔M(P25,P75),mmol/L〕 | eGFR〔M(P25,P75),ml·min-1·(1.73 m2)-1〕 | TC〔M(P25,P75),mmol/L〕b |
---|---|---|---|---|---|---|---|
FPG正常组 | 25 539 | 36(29,48) | 12 881/12 623 | 4.87(4.58,5.15) | 340.88(278.53,412.27) | 105.00(92.72,119.18) | 4.91(4.35,5.57) |
FPG升高组 | 3 062 | 47(36,57) | 1 851/1 204 | 5.85(5.70,6.12) | 367.84(301.32,436.58) | 101.08(88.89,115.18) | 5.22(4.59,5.84) |
Z(χ2)值 | -31.263 | 110.664a | -90.568 | -12.723 | -10.269 | -14.629 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
组别 | LDL-C〔M(P25,P75),mmol/L〕b | TG〔M(P25,P75),mmol/L〕b | SBP〔M(P25,P75),mm Hg〕b | DBP〔M(P25,P75),mm Hg〕b | MAP〔M(P25,P75),mm Hg〕b | BMI〔M(P25,P75),kg/m2〕b | |
FPG正常组 | 2.84(2.66,3.74) | 1.09(0.75,1.65) | 115(106,124) | 70(64,77) | 85.33(78.67,91.67) | 22.78(20.75,24.95) | |
FPG升高组 | 3.16(2.66,3.74) | 1.42(0.95,2.15) | 121(113,129) | 74(68,80) | 90.00(83.33,95.67) | 24.52(22.40,26.64) | |
Z(χ2)值 | -19.339 | -21.034 | -24.494 | -19.807 | -23.565 | -26.426 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
Table 1 Comparison of general information between the two groups of subjects
组别 | 例数 | 年龄〔M(P25,P75),岁〕 | 性别(男/女) | FPG〔M(P25,P75),mmol/L〕 | 尿酸〔M(P25,P75),mmol/L〕 | eGFR〔M(P25,P75),ml·min-1·(1.73 m2)-1〕 | TC〔M(P25,P75),mmol/L〕b |
---|---|---|---|---|---|---|---|
FPG正常组 | 25 539 | 36(29,48) | 12 881/12 623 | 4.87(4.58,5.15) | 340.88(278.53,412.27) | 105.00(92.72,119.18) | 4.91(4.35,5.57) |
FPG升高组 | 3 062 | 47(36,57) | 1 851/1 204 | 5.85(5.70,6.12) | 367.84(301.32,436.58) | 101.08(88.89,115.18) | 5.22(4.59,5.84) |
Z(χ2)值 | -31.263 | 110.664a | -90.568 | -12.723 | -10.269 | -14.629 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | |
组别 | LDL-C〔M(P25,P75),mmol/L〕b | TG〔M(P25,P75),mmol/L〕b | SBP〔M(P25,P75),mm Hg〕b | DBP〔M(P25,P75),mm Hg〕b | MAP〔M(P25,P75),mm Hg〕b | BMI〔M(P25,P75),kg/m2〕b | |
FPG正常组 | 2.84(2.66,3.74) | 1.09(0.75,1.65) | 115(106,124) | 70(64,77) | 85.33(78.67,91.67) | 22.78(20.75,24.95) | |
FPG升高组 | 3.16(2.66,3.74) | 1.42(0.95,2.15) | 121(113,129) | 74(68,80) | 90.00(83.33,95.67) | 24.52(22.40,26.64) | |
Z(χ2)值 | -19.339 | -21.034 | -24.494 | -19.807 | -23.565 | -26.426 | |
P值 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
组别 | 例数 | 年龄〔M(P25,P75),岁〕 | 性别(男/女) | FPG〔M(P25,P75),mmol/L〕 | 尿酸〔M(P25,P75),mmol/L〕 | TC〔M(P25,P75),mmol/L〕 | MAP〔M(P25,P75),mm Hg〕 | BMI( | eGFR〔M(P25,P75),ml·min-1·(1.73 m2)-1〕 |
---|---|---|---|---|---|---|---|---|---|
FPG正常组 | 2 346 | 46(35,55) | 1 423/923 | 5.32(5.12,5.46) | 362.54(300.43,425.72) | 5.15(4.60,5.75) | 89.33(83.33,95.00) | 24.30±2.78 | 99.71(88.75,113.76) |
FPG升高组 | 2 346 | 46(36,55) | 1 423/923 | 5.83(5.69,6.10) | 362.76(300.76,115.52) | 5.21(4.63,5.76) | 89.67(83.33,95.33) | 24.33±2.79 | 101.74(90.49,115.52) |
Z(t)值 | -0.519 | -59.317 | -0.075 | -1.636 | -0.945 | -0.326a | -3.208 | ||
P值 | 0.604 | <0.001 | 0.940 | 0.102 | 0.345 | 0.744 | 0.001 |
Table 2 Differences in estimated glomerular filtration rate between subjects with normal and elevated fasting plasma glucose at post-matching
组别 | 例数 | 年龄〔M(P25,P75),岁〕 | 性别(男/女) | FPG〔M(P25,P75),mmol/L〕 | 尿酸〔M(P25,P75),mmol/L〕 | TC〔M(P25,P75),mmol/L〕 | MAP〔M(P25,P75),mm Hg〕 | BMI( | eGFR〔M(P25,P75),ml·min-1·(1.73 m2)-1〕 |
---|---|---|---|---|---|---|---|---|---|
FPG正常组 | 2 346 | 46(35,55) | 1 423/923 | 5.32(5.12,5.46) | 362.54(300.43,425.72) | 5.15(4.60,5.75) | 89.33(83.33,95.00) | 24.30±2.78 | 99.71(88.75,113.76) |
FPG升高组 | 2 346 | 46(36,55) | 1 423/923 | 5.83(5.69,6.10) | 362.76(300.76,115.52) | 5.21(4.63,5.76) | 89.67(83.33,95.33) | 24.33±2.79 | 101.74(90.49,115.52) |
Z(t)值 | -0.519 | -59.317 | -0.075 | -1.636 | -0.945 | -0.326a | -3.208 | ||
P值 | 0.604 | <0.001 | 0.940 | 0.102 | 0.345 | 0.744 | 0.001 |
组别 | 例数 | eGFR值〔ml·min-1·(1.73 m2)-1〕 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
60~70 | >70~80 | >80~90 | >90~100 | >100~110 | >110~120 | >120~130 | >130~140 | >140~150 | >150 | ||
FPG正常组 | 2 346 | 50(2.13) | 201(8.57) | 404(17.22) | 538(22.93) | 444(18.93) | 312(13.30) | 179(7.63) | 107(4.56) | 58(2.47) | 53(2.26) |
FPG升高组 | 2 346 | 39(1.66) | 157(6.69) | 368(15.69) | 514(21.91) | 479(20.42) | 346(14.75) | 220(9.38) | 119(5.07) | 54(2.30) | 50(2.13) |
Table 3 Frequency distribution of eGFR in subjects with normal and elevated fasting plasma glucose
组别 | 例数 | eGFR值〔ml·min-1·(1.73 m2)-1〕 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
60~70 | >70~80 | >80~90 | >90~100 | >100~110 | >110~120 | >120~130 | >130~140 | >140~150 | >150 | ||
FPG正常组 | 2 346 | 50(2.13) | 201(8.57) | 404(17.22) | 538(22.93) | 444(18.93) | 312(13.30) | 179(7.63) | 107(4.56) | 58(2.47) | 53(2.26) |
FPG升高组 | 2 346 | 39(1.66) | 157(6.69) | 368(15.69) | 514(21.91) | 479(20.42) | 346(14.75) | 220(9.38) | 119(5.07) | 54(2.30) | 50(2.13) |
人群 | rs值 | P值 |
---|---|---|
全人群 | -0.047 | <0.001 |
FPG正常组 | -0.018 | 0.005 |
FPG升高组 | -0.057 | 0.002 |
匹配后人群 | 0.065 | <0.001 |
匹配后FPG正常组 | -0.028 | 0.176 |
匹配后FPG升高组 | 0.127 | <0.001 |
Table 4 Correlation analysis between FPG and eGFR before and after matching
人群 | rs值 | P值 |
---|---|---|
全人群 | -0.047 | <0.001 |
FPG正常组 | -0.018 | 0.005 |
FPG升高组 | -0.057 | 0.002 |
匹配后人群 | 0.065 | <0.001 |
匹配后FPG正常组 | -0.028 | 0.176 |
匹配后FPG升高组 | 0.127 | <0.001 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
拾莉,刘学奎,龚莹,等. 空腹血糖受损患者血尿酸与肾小球滤过率的相关性分析[J]. 江苏大学学报(医学版),2020,30(4):347-350. DOI:10.13312/j.issn.1671-7783.y200008.
|
[7] |
|
[8] |
AMERICAN DIABETES ASSOCIATION. 2. classification and diagnosis of diabetes:Standards of medical care in diabetes-2021[J]. Diabetes Care,2021,44(Suppl 1):S15-33. DOI:10.2337/dc21-S002.
|
[9] |
|
[10] |
|
[11] |
中华医学会糖尿病学分会.中国2型糖尿病防治指南(2017年版)[J].中华糖尿病杂志,2018,10(1):4-67. DOI:10.3760/cma.j.issn.1674-5809.2018.01.003.
|
[12] |
|
[13] |
|
[14] |
|
[1] | BAI Haiwei, MI Xiaokun, LIU Qingrui, ZHU Lin, WANG Yingnan, LIU Junyan, HAN Ying. Predictive Value of Serum Uric Acid in Perioperative Acute Ischemic Stroke in Patients with Non-small Cell Lung Cancer [J]. Chinese General Practice, 2023, 26(36): 4545-4551. |
[2] | CHU Xiaojing, LI Jun, FU Yanqin, LIU Danqing, LIU Aiping, ZHANG Yuanyuan. Effect of Human Body Composition and Serum Biochemical Indicators on the Accuracy of Flash Glucose Monitoring System [J]. Chinese General Practice, 2023, 26(35): 4433-4438. |
[3] | XIE Xuemei, GAO Jing, BAI Dingxi, LU Xianying, HE Jiali, LI Yue. Current Status of Polypharmacy in the Elderly and Its Influencing Factors: a Meta-analysis [J]. Chinese General Practice, 2023, 26(35): 4394-4403. |
[4] | WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335. |
[5] | LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301. |
[6] | HAO Aihua, ZENG Weilin, LI Guanhai, XIA Yinghua, CHEN Liang. Current Situation of the Construction of Family Doctor Team: an Investigation Based on the Perspective of General Practitioners [J]. Chinese General Practice, 2023, 26(34): 4261-4268. |
[7] | QIN Fengyin, ZHANG Qishan, LAI Jinjia, HUANG Yimin, HAN Guoyin, SUN Xinglan, WANG Fen, TAN Yibing. Current Status and Influencing Factors of the Intention to Screen for High-risk Stroke among Community Residents in Guangdong [J]. Chinese General Practice, 2023, 26(34): 4283-4289. |
[8] | WANG Lina, GAO Pengfei, CAO Fan, GE Ying, YAN Wei, HE Daikun. Analysis of the Prevalence and Influencing Factors of Non-alcoholic Fatty Liver Disease in Different Gender Groups [J]. Chinese General Practice, 2023, 26(33): 4143-4151. |
[9] | LIANG Xuan, NA Feiyang, QIN Mengyao, YANG Hui, GUO Li, GUO Qi, REN Lei, CHEN De, LIU Donghai, ZHANG Rongfang. Clinical Characteristics and Influencing Factors of Bronchial Asthma Combined with Obstructive Sleep Apnea-hypopnea Syndrome in Children [J]. Chinese General Practice, 2023, 26(33): 4225-4230. |
[10] | LI Qianqian, CHEN Xunrui, ZHANG Wenying, YUAN Haihua, ZHANG Yanjie, JIANG Bin, LIU Feng. Demand and Influencing Factors for Community Health Services during Chemotherapy of Patients with Advanced Cancer [J]. Chinese General Practice, 2023, 26(33): 4173-4180. |
[11] | ZHANG Jin, DING Zhiguo, QI Shuo, LI Ying, LI Weiqiang, ZHANG Yuanyuan, ZHOU Tong. Relationship between Serum Thyroid Hormone Levels and Prognosis during Hospitalization in Heart Failure Patients [J]. Chinese General Practice, 2023, 26(33): 4125-4129. |
[12] | ZHOU Yuyu, GAO Chuan, CUI Puan, WANG Yaping, HE Zhong. Influencing Factors of Shared Decision Making between Doctors and Patients in Menopausal Hormone Therapy in Patients with Menopausal Syndrome [J]. Chinese General Practice, 2023, 26(33): 4181-4186. |
[13] | GAO Dekang, WEI Shaohua, MA Xiaoming, DU Peng, XING Chungen, CAO Chun. Risk Factors for Loss of Skeletal Muscle Mass and Its Correlation with Complications after Major Hepatectomy for Liver Cancer [J]. Chinese General Practice, 2023, 26(32): 4031-4037. |
[14] | WANG Minghuan, LI Yuhong, YU Min, WANG Yougang, YU Qiaozhi, YANG Fangfang, YUAN Dehui, ZHANG Liu. Effect of Allostatic Load on Adverse Pregnancy Outcomes of Women in Late Pregnancy [J]. Chinese General Practice, 2023, 26(32): 4064-4069. |
[15] | YUAN Dehui, LI Yuhong, XIONG Min, YU Min, MA Ruiliang, YANG Fangfang, YU Qiaozhi, WANG Minghuan. Status and Influencing Factors of Allostatic Load in Pregnant Women at Different Trimesters [J]. Chinese General Practice, 2023, 26(32): 4057-4063. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||